QuidelOrtho Corp. Stock
€9.65
Your prediction
QuidelOrtho Corp. Stock
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
Cons
Performance of QuidelOrtho Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp. | 0.370% | -10.734% | -32.296% | -57.833% | -61.544% | -88.352% | -89.973% |
| Veeva Systems A | 1.380% | -6.147% | -16.264% | -31.346% | -30.235% | -20.853% | -42.389% |
| Thermo Fisher Scientific Inc. | 1.050% | -8.815% | -3.083% | 4.817% | -19.203% | -23.241% | -1.041% |
| Waters Corp. | 0.450% | -1.771% | 2.385% | -9.885% | -18.792% | -4.929% | 4.803% |
Comments
News
Rice Hall James Buys QuidelOrtho Stock
On Feb. 13, 2026, Rice Hall James & Associates, LLC disclosed a buy of QuidelOrtho (NASDAQ:QDEL) in the fourth quarter.
An SEC filing dated Feb. 13, 2026, shows Rice Hall James & Associates, LLC
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires
Matthew Strobeck, a Board Director at QuidelOrtho Corp. (NASDAQ:QDEL), reported the purchase of 10,000 common shares on Feb. 13, 2026, for a total transaction value of ~$240,000, as disclosed in a
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs
On November 14, New York City-based Newtyn Management disclosed a purchase of 994,332 shares of QuidelOrtho Corporation (QDEL), increasing its stake by approximately $30.4 million.
According to a


